MétaCan
Menu
Back to cohort

IMPACT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS ON CORONARY HEART DISEASE EVENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 299,871 PATIENTS

2021· review· en· W3155257455 on OpenAlexaboutno aff
Manal Alosaimi, Nur Aishah Che Roos, Anwar M. Alnakhli, John G.F. Cleland, Sandosh Padmanabhan

Bibliographic record

VenueJournal of Hypertension · 2021
Typereview
Languageen
FieldMedicine
TopicBlood Pressure and Hypertension Studies
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineInternal medicineRelative riskAnginaMyocardial infarctionCardiologyHeart failurePlaceboMeta-analysisConfidence intervalLower riskRandomized controlled trialCanadian Cardiovascular SocietyUnstable anginaBlood pressurePathology

Abstract

fetched live from OpenAlex

Objective: To evaluate the effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) on risk of myocardial infarction (MI), angina & heart failure (HF) in patients with or at high-risk of cardiovascular disease (CVD). Design and method: A meta-analysis of randomized-controlled trials was performed. Bibliographic databases were searched until 31 July 2019 to identify all trials of ACEIs & ARBs versus control (placebo or active) & supported with head-to-head trials. Trials with at least 100 participants & at least one year's follow-up were eligible. Studies were excluded if they were redacted or combined ACEIs with ARBs. Outcomes were MI, angina pectoris & HF. Dichotomous data was analysed using risk ratio (RR) measure and its 95% confidence interval (CI) with random-effects model. A random-effects meta-regression analysis was performed to explore role systolic blood pressure (SBP) reduction achieved. Results: We identified 32 trials of ACEIs, 38 of ARBs compared with control & 8 direct comparison trials. Altogether, trials enrolled 299,871 patient-years of follow-up. Compared with control, ACEIs had a 16% lower MI risk (RR, 0.84; 95% CI, 0.79–0.90; p < 0.00001) & 17% lower HF (RR, 0.83; 95% CI, 0.76–0.92; p = 0.0003); while no such benefit was seen for angina (RR;1.02; 95% CI, 0.94–1.11; p = 0.63). ARBs was reduced risk of HF by 14% (RR, 0.86; 95% CI 0.81–0.91; p < 0.00001). While, no benefit was appeared with MI risk (RR,0.97; 95% CI 0.89–1.06; p = 0.55) & angina (RR, 0.99; 95% CI 0.88–1.11; p = 0.87). Trials comparing ARBs with ACEIs revealed no difference in outcomes. The meta-regression suggested that independently of BP reduction, ACEIs had a 11% lower MI (RR,0.89; 95% CI 0.81–0.98; p = 0.02) & ARBs provide a 15% reduction in HF (RR, 0.85; 95% CI 0.77–0.93; p = 0.001). Whereas, prevention of HF by ACEIs was explained mainly by SBP reduction achieved (p = 0.01). Conclusions: In patients with or at high-risk of CVD, ARBs and ACEIs reduced risk of HF. However, they did not appear to be case for angina. Moreover, ACEIs result in a further reduction of MI whereas ARBs had no such benefit. However, evidence from direct comparison trials suggests similar effects on all outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.011
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.019
Threshold uncertainty score0.059

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0110.019
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0190.032
Bibliometrics0.0060.007
Science and technology studies0.0010.001
Scholarly communication0.0030.001
Open science0.0020.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.079
GPT teacher head0.333
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueJournal of HypertensionSame topicBlood Pressure and Hypertension StudiesFrench-language works237,207